TNDM
$10.69
Revenue | $240.68Mn |
Net Profits | $-52.4Mn |
Net Profit Margins | -21.77% |
Tandem Diabetes Care, Inc.’s revenue jumped 8.46% since last year same period to $240.68Mn in the Q2 2025. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated 2.67% jump in its revenue since last 3-months.
Tandem Diabetes Care, Inc.’s net profit fell -70.05% since last year same period to $-52.4Mn in the Q2 2025. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated 59.86% jump in its net profits since last 3-months.
Tandem Diabetes Care, Inc.’s net profit margin fell -56.79% since last year same period to -21.77% in the Q2 2025. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated 60.91% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.32 |
EPS Estimate Current Year | -0.32 |
Tandem Diabetes Care, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.32 - a 19.48% jump from last quarter’s estimates.
Tandem Diabetes Care, Inc.’s earning per share (EPS) estimates for the current year stand at -0.32.
Earning Per Share (EPS) | 0 |
Tandem Diabetes Care, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Tandem Diabetes Care, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-04-30 | -0.61 | -0.67 | -9.46% |
2025-10-29 | -0.32 | 0 | 100% |
2025-08-06 | -0.4 | -0.78 | -95% |